833 related articles for article (PubMed ID: 26755436)
1. Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.
Zhou Y; Liu Y; Hussmann D; Brøgger P; Al-Saaidi RA; Tan S; Lin L; Petersen TS; Zhou GQ; Bross P; Aagaard L; Klein T; Rønn SG; Pedersen HD; Bolund L; Nielsen AL; Sørensen CB; Luo Y
Cell Mol Life Sci; 2016 Jul; 73(13):2543-63. PubMed ID: 26755436
[TBL] [Abstract][Full Text] [Related]
2. Homologous recombination-mediated targeted integration in monkey embryos using TALE nucleases.
Chu C; Yang Z; Yang J; Yan L; Si C; Kang Y; Chen Z; Chen Y; Ji W; Niu Y
BMC Biotechnol; 2019 Jan; 19(1):7. PubMed ID: 30646876
[TBL] [Abstract][Full Text] [Related]
3. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
[TBL] [Abstract][Full Text] [Related]
4. The CRISPR-Cas system for plant genome editing: advances and opportunities.
Kumar V; Jain M
J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
[TBL] [Abstract][Full Text] [Related]
5. Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.
Cottle RN; Lee CM; Archer D; Bao G
Sci Rep; 2015 Nov; 5():16031. PubMed ID: 26558999
[TBL] [Abstract][Full Text] [Related]
6. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
7. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
[TBL] [Abstract][Full Text] [Related]
9. Efficient generation of targeted and controlled mutational events in porcine cells using nuclease-directed homologous recombination.
Butler JR; Santos RMN; Martens GR; Ladowski JM; Wang ZY; Li P; Tector M; Tector AJ
J Surg Res; 2017 May; 212():238-245. PubMed ID: 28550913
[TBL] [Abstract][Full Text] [Related]
10. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
Liang Z; Zhang K; Chen K; Gao C
J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
[TBL] [Abstract][Full Text] [Related]
11. A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9.
Cuculis L; Schroeder CM
Annu Rev Chem Biomol Eng; 2017 Jun; 8():577-597. PubMed ID: 28489428
[TBL] [Abstract][Full Text] [Related]
12. Functional Evaluation of CRISPR Activity by the Dual-Fluorescent Surrogate System: C-Check.
Lin L; Luo Y
Methods Mol Biol; 2019; 1961():67-77. PubMed ID: 30912040
[TBL] [Abstract][Full Text] [Related]
13. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System.
Bian WP; Chen YL; Luo JJ; Wang C; Xie SL; Pei DS
ACS Synth Biol; 2019 Apr; 8(4):621-632. PubMed ID: 30955321
[TBL] [Abstract][Full Text] [Related]
14. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
Zhang Y; Huang H; Zhang B; Lin S
Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
[TBL] [Abstract][Full Text] [Related]
15. An efficient method to enrich for knock-out and knock-in cellular clones using the CRISPR/Cas9 system.
Niccheri F; Pecori R; Conticello SG
Cell Mol Life Sci; 2017 Sep; 74(18):3413-3423. PubMed ID: 28421278
[TBL] [Abstract][Full Text] [Related]
16. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
Najah S; Saulnier C; Pernodet JL; Bury-Moné S
BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
[TBL] [Abstract][Full Text] [Related]
17. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
Kim HM; Colaiácovo MP
Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
20. Enhanced CRISPR/Cas9-mediated biallelic genome targeting with dual surrogate reporter-integrated donors.
Wu Y; Xu K; Ren C; Li X; Lv H; Han F; Wei Z; Wang X; Zhang Z
FEBS Lett; 2017 Mar; 591(6):903-913. PubMed ID: 28214366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]